Romulus Brazzell

Technik-/Wissenschafts-/F&E-Leiter bei KALA BIO, INC.

Vermögen: 436 $ am 30.06.2026

73 Jahre

57 Beziehungen

Health Technology

Consumer Services

Finance

Profil

Romulus Kim Brazzell is currently Director at Mimetogen Pharmaceuticals, Inc. since 2024 and Chief Medical Officer, Head-Research & Development at Kala Bio, Inc. since 2021.
Former positions include Associate Director-Research & Development at Alcon Laboratories, Inc. from 1990 to 1991; Executive VP-Medical & Scientific Affairs at Inspire Pharmaceuticals, Inc. from 2010 to 2011; Senior Vice President-US Research & Development at Novartis Ophthalmics, Inc. from 2000 to 2004; Chief Medical Officer at Mimetogen Pharmaceuticals, Inc. from 2012 to 2015; Vice President-Research & Development at Ciba Vision Ophthalmics Co. from 1996 to 2000; and Principal at Acuity Advisors LLC from 2014 to 2018.
Education includes undergraduate and doctorate degrees from the University of Kentucky.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
KALA BIO, INC. 0 %	29.12.2025	252 ( 0 % )	436 $	30.06.2026

Aktive Positionen von Romulus Brazzell

Unternehmen	Position	Beginn
KALA BIO, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.02.2013
Mimetogen Pharmaceuticals, Inc. Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer	Direktor/Vorstandsmitglied	01.01.2024

Alle aktiven Positionen von Romulus Brazzell

Ehemalige bekannte Positionen von Romulus Brazzell

Unternehmen	Position	Ende
Acuity Advisors LLC Acuity Advisors LLC Investment ManagersFinance Provides investment advice	Corporate Officer/Principal	01.07.2018
Mimetogen Pharmaceuticals, Inc. Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer	Technik-/Wissenschafts-/F&E-Leiter	01.12.2015
Inspire Pharmaceuticals, Inc. Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products	Technik-/Wissenschafts-/F&E-Leiter	01.01.2011
Novartis Ophthalmics, Inc. Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs	Technik-/Wissenschafts-/F&E-Leiter	01.01.2004
Ciba Vision Ophthalmics Co.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2000

Sehen Sie sich die Erfahrung von Romulus Brazzell im Detail an

Ausbildung von Romulus Brazzell

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Romulus Brazzell im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	8
Inspire Pharmaceuticals, Inc. Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products	Health Technology
Kala Bio, Inc. Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies	Health Technology
Alcon Laboratories, Inc. Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company	Health Technology
University of Kentucky University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Ophthalmics, Inc. Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs	Health Technology
Mimetogen Pharmaceuticals, Inc. Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer	Health Technology
Ciba Vision Ophthalmics Co.
Acuity Advisors LLC Acuity Advisors LLC Investment ManagersFinance Provides investment advice	Finance